TuHURA Biosciences Inc

Research TuHURA Biosciences Inc (HURA) on Bullrun: market cap USD 145.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHURA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 145.83M
• Financial periodFY2025
• Net income-USD 30.05M
• Free cash flow-USD 27.71M

Valuation Snapshot

latest market cap is USD 145.83M.

About TuHURA Biosciences Inc

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda;

Frequently asked questions

What is TuHURA Biosciences Inc's market cap?

TuHURA Biosciences Inc's market capitalization is USD 145.83M.

What does TuHURA Biosciences Inc do?

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.